Report Detail
Global Nuclear Medicine & Radio Pharmaceuticals Market Insights and Forecast to 2026
- RnM4151501 |
- 21 August, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Nuclear Medicine & Radio Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine & Radio Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nuclear Medicine & Radio Pharmaceuticals market is segmented into
Diagnostic Medicine
Therapeutic Medicine
Segment by Application, the Nuclear Medicine & Radio Pharmaceuticals market is segmented into
Diagnostic Applications
Therapeutic Applications
Regional and Country-level Analysis
The Nuclear Medicine & Radio Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine & Radio Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
Nuclear Medicine & Radio Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Medicine & Radio Pharmaceuticals business, the date to enter into the Nuclear Medicine & Radio Pharmaceuticals market, Nuclear Medicine & Radio Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd
1 Study Coverage
- 1.1 Nuclear Medicine & Radio Pharmaceuticals Product Introduction
- 1.2 Market Segments
- 1.3 Key Nuclear Medicine & Radio Pharmaceuticals Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size Growth Rate by Type
- 1.4.2 Diagnostic Medicine
- 1.4.3 Therapeutic Medicine
- 1.5 Market by Application
- 1.5.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size Growth Rate by Application
- 1.5.2 Diagnostic Applications
- 1.5.3 Therapeutic Applications
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size, Estimates and Forecasts
- 2.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue 2015-2026
- 2.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales 2015-2026
- 2.2 Global Nuclear Medicine & Radio Pharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Nuclear Medicine & Radio Pharmaceuticals Competitor Landscape by Players
- 3.1 Nuclear Medicine & Radio Pharmaceuticals Sales by Manufacturers
- 3.1.1 Nuclear Medicine & Radio Pharmaceuticals Sales by Manufacturers (2015-2020)
- 3.1.2 Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
- 3.2 Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturers
- 3.2.1 Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturers (2015-2020)
- 3.2.2 Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Nuclear Medicine & Radio Pharmaceuticals Revenue in 2019
- 3.2.5 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Nuclear Medicine & Radio Pharmaceuticals Price by Manufacturers
- 3.4 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 Nuclear Medicine & Radio Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Nuclear Medicine & Radio Pharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine & Radio Pharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Type (2015-2020)
- 4.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2015-2020)
- 4.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Type (2015-2020)
- 4.1.3 Nuclear Medicine & Radio Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Type (2021-2026)
- 4.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast by Type (2021-2026)
- 4.2.3 Nuclear Medicine & Radio Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Application (2015-2020)
- 5.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2015-2020)
- 5.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Application (2015-2020)
- 5.1.3 Nuclear Medicine & Radio Pharmaceuticals Price by Application (2015-2020)
- 5.2 Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Application (2021-2026)
- 5.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Nuclear Medicine & Radio Pharmaceuticals Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Nuclear Medicine & Radio Pharmaceuticals by Country
- 6.1.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales by Country
- 6.1.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Type
- 6.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Application
7 Europe
- 7.1 Europe Nuclear Medicine & Radio Pharmaceuticals by Country
- 7.1.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Country
- 7.1.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Type
- 7.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals by Region
- 8.1.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Region
- 8.1.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Type
- 8.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Nuclear Medicine & Radio Pharmaceuticals by Country
- 9.1.1 Latin America Nuclear Medicine & Radio Pharmaceuticals Sales by Country
- 9.1.2 Latin America Nuclear Medicine & Radio Pharmaceuticals Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Type
- 9.3 Central & South America Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals by Country
- 10.1.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Country
- 10.1.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Type
- 10.3 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Facts & Figures by Application
11 Company Profiles
- 11.1 GE Healthcare
- 11.1.1 GE Healthcare Corporation Information
- 11.1.2 GE Healthcare Description and Business Overview
- 11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.1.5 GE Healthcare Related Developments
- 11.2 Philips Healthcare
- 11.2.1 Philips Healthcare Corporation Information
- 11.2.2 Philips Healthcare Description and Business Overview
- 11.2.3 Philips Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.2.5 Philips Healthcare Related Developments
- 11.3 Siemens Healthcare
- 11.3.1 Siemens Healthcare Corporation Information
- 11.3.2 Siemens Healthcare Description and Business Overview
- 11.3.3 Siemens Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.3.5 Siemens Healthcare Related Developments
- 11.4 Toshiba
- 11.4.1 Toshiba Corporation Information
- 11.4.2 Toshiba Description and Business Overview
- 11.4.3 Toshiba Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Toshiba Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.4.5 Toshiba Related Developments
- 11.5 Hitachi
- 11.5.1 Hitachi Corporation Information
- 11.5.2 Hitachi Description and Business Overview
- 11.5.3 Hitachi Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Hitachi Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.5.5 Hitachi Related Developments
- 11.6 Carestream
- 11.6.1 Carestream Corporation Information
- 11.6.2 Carestream Description and Business Overview
- 11.6.3 Carestream Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Carestream Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.6.5 Carestream Related Developments
- 11.7 Esaote
- 11.7.1 Esaote Corporation Information
- 11.7.2 Esaote Description and Business Overview
- 11.7.3 Esaote Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Esaote Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.7.5 Esaote Related Developments
- 11.8 Shimadzu
- 11.8.1 Shimadzu Corporation Information
- 11.8.2 Shimadzu Description and Business Overview
- 11.8.3 Shimadzu Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.8.5 Shimadzu Related Developments
- 11.9 TriFoil Imaging
- 11.9.1 TriFoil Imaging Corporation Information
- 11.9.2 TriFoil Imaging Description and Business Overview
- 11.9.3 TriFoil Imaging Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.9.5 TriFoil Imaging Related Developments
- 11.10 Biosensors International Group, Ltd
- 11.10.1 Biosensors International Group, Ltd Corporation Information
- 11.10.2 Biosensors International Group, Ltd Description and Business Overview
- 11.10.3 Biosensors International Group, Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.10.5 Biosensors International Group, Ltd Related Developments
- 11.1 GE Healthcare
- 11.1.1 GE Healthcare Corporation Information
- 11.1.2 GE Healthcare Description and Business Overview
- 11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Products Offered
- 11.1.5 GE Healthcare Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Nuclear Medicine & Radio Pharmaceuticals Market Estimates and Projections by Region
- 12.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Regions 2021-2026
- 12.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast by Regions 2021-2026
- 12.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast (2021-2026)
- 12.2.1 North America: Nuclear Medicine & Radio Pharmaceuticals Sales Forecast (2021-2026)
- 12.2.2 North America: Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast (2021-2026)
- 12.2.3 North America: Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast by Country (2021-2026)
- 12.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast (2021-2026)
- 12.3.1 Europe: Nuclear Medicine & Radio Pharmaceuticals Sales Forecast (2021-2026)
- 12.3.2 Europe: Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast (2021-2026)
- 12.3.3 Europe: Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Nuclear Medicine & Radio Pharmaceuticals Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Nuclear Medicine & Radio Pharmaceuticals Sales Forecast (2021-2026)
- 12.5.2 Latin America: Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Nuclear Medicine & Radio Pharmaceuticals Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Nuclear Medicine & Radio Pharmaceuticals Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Nuclear Medicine & Radio Pharmaceuticals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Nuclear Medicine & Radio Pharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Nuclear Medicine & Radio Pharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Nuclear Medicine & Radio Pharmaceuticals. Industry analysis & Market Report on Nuclear Medicine & Radio Pharmaceuticals is a syndicated market report, published as Global Nuclear Medicine & Radio Pharmaceuticals Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Nuclear Medicine & Radio Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
